Program

Home

J. van de Wijgert: Microbicides: State-of-the-Art


Janneke Janneke van de Wijgert, PhD, is a senior epidemiologist at IATEC Foundation and the Center for Poverty-related Communicable Diseases (CPCD) at the AMC, University of Amsterdam. She is/was Principal or co-investigator on several safety and effectiveness trials of vaginal microbicides for HIV prevention, as well as other
HIV prevention intervention and reproductive health studies. Dr. van de Wijgert was co-founder of two clinical research sites in developing countries: Projet Ubuzima in Kigali, Rwanda and the University of Zimbabwe and University of California at San Francisco (UZ-UCSF) Women’s Health Program in Harare, Zimbabwe. In the past, she was employed as Program Associate at the Population Council in New York, visiting lecturer at the University of Zimbabwe Medical School, and Director of the UZ-UCSF Women’s Health Program in Harare, Zimbabwe.Dr. van de Wijgert is currently a regular consultant to the Population Council in New York and the UZ-UCSF Women’s Health Program. She has published over 30 papers, serves on several advisory and steering committees, and is a reviewer for scientific journals.Key Publications Janneke van de Wijgert
  1. Van de Wijgert J, Altini L, Jones H, de Kock A, Young T, Williamson AL, Hoosen A, Coetzee N. Two methods of self-sampling compared to clinician-sampling to detect reproductive tract infections in Gugulethu, South Africa. (Accepted for publication in Sexually Transmitted Diseases).
  2. Braunstein S, van de Wijgert, J. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing. J Women’s Health, 2005;14(5):424-33.
  3. Van de Wijgert J, Coggins C. Microbicides to prevent heterosexual transmission of HIV: Ten years down the road. AIDScience (www.aidscience.org); 2, January 2002.
  4. Van de Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K. Phase I trial of the topical microbicide BufferGel: Safety results from four international sites. Journal of Acquired Immunodeficiency Syndromes, 2001;26(1):21-7.
  5. Van de Wijgert J, Mason P, Gwanzura L, Mbizvo M, Chirenje Z, Iliff V, Shiboski S, Padian N. The effect of intravaginal practices on the vaginal flora of Zimbabwean women. The Journal of Infectious Diseases, 2000;181(2):587-94.